Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

06.04.2026

1 BMJ
1 Indian Pediatr
1 Infect Immun
2 J Infect Dis
1 J Virol
1 MMWR Morb Mortal Wkly Rep
1 Nat Immunol
2 PLoS Comput Biol
6 PLoS One
22 Vaccine
2 Virology
2 Virus Res


    BMJ

  1. WISE J
    RSV vaccination programme expanded to 3 million more older people.
    BMJ. 2026;393:s646.
    >> Share


    Indian Pediatr

  2. MOHAN N
    HPV Vaccination: A Transformative Step Towards Eliminating Cervical Cancer in India.
    Indian Pediatr. 2026 Mar 31. doi: 10.1007/s13312-026-00326.
    >> Share


    Infect Immun

  3. THAYER TC, Cox A, Gonzalez E, Mangiafesto J, et al
    Lipidated Protein D vaccination elicits humoral and cellular responses and protects mice against challenge with non-typeable Haemophilus influenzae.
    Infect Immun. 2026 Mar 31:e0064725. doi: 10.1128/iai.00647.
    >> Share


    J Infect Dis

  4. LUTZ CS, Filardo TD, DeJonge PM, Gretsch S, et al
    Effectiveness of Measles-Mumps-Rubella Vaccination Among Persons Residing in a Congregate Migrant Shelter During a Measles Outbreak: An Observational Cohort Study.
    J Infect Dis. 2026 Apr 1:jiaf650. doi: 10.1093.
    >> Share

  5. HUNT JH, Damhorst GL, Parsons R, Frediani JK, et al
    Peak Nasal SARS-CoV-2 and Influenza Viral Loads Relative to Symptom Onset, 2022-2025: Impact of Vaccination and Implications for Multiplexed Testing.
    J Infect Dis. 2026 Apr 1:jiag169. doi: 10.1093.
    >> Share


    J Virol

  6. KIM K-H, Hwang HS, Pal SS, Tien Le CT, et al
    Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity.
    J Virol. 2026 Mar 27:e0022926. doi: 10.1128/jvi.00229.
    >> Share


    MMWR Morb Mortal Wkly Rep

  7. MEGHANI M, Garacci Z, Razzaghi H, de Perio MA, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2024-25 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:164-171.
    >> Share


    Nat Immunol

  8. CHAULAGAIN S, Liu JA, McCombs JE, Klein SL, et al
    Sex differences in immune responses to viruses, bacteria and vaccines.
    Nat Immunol. 2026;27:660-673.
    >> Share


    PLoS Comput Biol

  9. NIGHTINGALE ES, Pham-Minh L, Bello IM, Okrior S, et al
    Sub-national modelling of surveillance sensitivity to inform declaration of disease elimination: A retrospective validation against the elimination of wild poliovirus in Nigeria.
    PLoS Comput Biol. 2026;22:e1013984.
    >> Share

  10. ORSINELLI-RIVERS S, Beaglehole D, Einav T
    CAPYBARA: A generalizable framework for predicting serological measurements across human cohorts.
    PLoS Comput Biol. 2026;22:e1014129.
    >> Share


    PLoS One

  11. BRAUN J, Hill ED, Contreras E, Yasuda M, et al
    Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoires.
    PLoS One. 2026;21:e0343939.
    >> Share

  12. CHANG T, Deng C, Xie L, Zheng Y, et al
    Stirred tank bioreactor process for chikungunya vaccine candidate VEEV-DeltaC-CHIKV.
    PLoS One. 2026;21:e0344564.
    >> Share

  13. AWAD R, Rahal M, Henieneh AM, Salameh P, et al
    Social determinants of vaccine hesitancy among the Lebanese parents: A cross-sectional Study.
    PLoS One. 2026;21:e0345153.
    >> Share

  14. OBENG MA, Okwan DK, Boateng CO, Scott GY, et al
    Towards hepatitis B elimination in Ghana: vaccination coverage and its predictors among informal sector workers in Kejetia, Kumasi, Ghana.
    PLoS One. 2026;21:e0334205.
    >> Share

  15. KIJERA B, Sowe A, Bobb M, Jarjusey S, et al
    Timeliness of routine vaccination among 24-35 months children in Urban Gambia.
    PLoS One. 2026;21:e0346048.
    >> Share

  16. IUNES FM, Aranha Rossi T, Soares F, Torres TS, et al
    Factors associated with COVID-19 vaccination schedule completion among adults in high-social-vulnerability neighborhoods in two Brazilian state capitals: A cross-sectional study.
    PLoS One. 2026;21:e0346091.
    >> Share


    Vaccine

  17. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.
    Vaccine. 2026;80:128544.
    >> Share

  18. YANG S, Dai D, Kang Z, Zhang L, et al
    Immunogenicity and safety of a quadrivalent recombinant human papillomavirus vaccine (type 6/11/16/18) (Hansenula polymorpha): A randomized controlled phase 2 non-inferiority clinical trial.
    Vaccine. 2026;80:128527.
    >> Share

  19. CALLEWAERT K, Lavreys L, Willems W, van Rosmalen MGM, et al
    Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials.
    Vaccine. 2026;79:128500.
    >> Share

  20. LUCIDARME J, Clark SA, Borrow R, Murthy AK, et al
    Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university "South West Outbreak" strain isolates.
    Vaccine. 2026;80:128503.
    >> Share

  21. PAN H, Zhao J, Yang J, Cao W, et al
    A ?ssaV deletion attenuates Salmonella Choleraesuis to generate a self-limiting, immunogenic vaccine candidate.
    Vaccine. 2026;80:128546.
    >> Share

  22. CHAN CP, Wong NS, Lee SS
    Normalising enhanced influenza vaccines as a strategy to promote vaccination uptake in healthcare workers: Insights from a discrete choice experiment.
    Vaccine. 2026;80:128539.
    >> Share

  23. WU D, Liu K
    Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov models.
    Vaccine. 2026;80:128536.
    >> Share

  24. VAN DE BURGWAL LHM, Pronker ES, Herz J
    Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment.
    Vaccine. 2026;80:128525.
    >> Share

  25. QU S, Zhou M, Campy KS, Bu P, et al
    An integrated health belief model and protection motivation theory approach to understanding herpes zoster vaccination intention among older adults in China.
    Vaccine. 2026;80:128508.
    >> Share

  26. PHIJFFER EWEM, Sivakumar C, van den Hoogen A, Crombag NMTH, et al
    Preferences of Dutch pregnant women for RSV immunisation - a mixed method study.
    Vaccine. 2026;78:128409.
    >> Share

  27. SHIGAYEVA A, Coleman BL, Golden AR, Martin I, et al
    Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era.
    Vaccine. 2026;78:128351.
    >> Share

  28. SABATE M, Riera-Arnau J, Ballarin E, Pares-Badell O, et al
    Validation of Guillain-Barre syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria.
    Vaccine. 2026;78:128397.
    >> Share

  29. TSCHERNE A, Krammer F
    Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2.
    Vaccine. 2026;79:128467.
    >> Share

  30. LIU Y, Wu B, Wei M, Gong R, et al
    E-health literacy and herpes zoster vaccination intention: Health belief pathways and socioeconomic inequalities.
    Vaccine. 2026;80:128502.
    >> Share

  31. ROBERTSON AH, Wolf AS, Fossum E, Solum G, et al
    Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections.
    Vaccine. 2026;80:128511.
    >> Share

  32. PODER A, Trinidad-Aseron M, Van Twuijver E, Versage E, et al
    Immunogenicity and safety of MF59-adjuvanted H5N1 pandemic influenza vaccine in healthy infants and children: a phase 2 randomized, observer-blind, multicenter study.
    Vaccine. 2026;80:128504.
    >> Share

  33. ALKAN C, Jurado-Cobena E, Ikegami T
    Evaluation of Rift Valley fever vaccine candidates in pregnant rodent models.
    Vaccine. 2026;80:128526.
    >> Share

  34. HASAN AZ, Dombola AM, Prosperi C, Mufwambi W, et al
    Assessing the effectiveness of school-based vaccination checks to identify and reach un - and under-vaccinated students in Zambia.
    Vaccine. 2026;79:128453.
    >> Share

  35. COORAY U, Singh A, Peres MA
    Long-term impacts of HPV vaccination strategies on HPV related Cancer burden among Singaporean female population: A prospective simulation using proportional multistate lifetables.
    Vaccine. 2026;80:128513.
    >> Share

  36. DLOUHY P, Petras M, Lesna IK, Macalik R, et al
    Transient elevation of NT-proBNP after mRNA COVID-19 vaccination in healthy adults: A longitudinal biomarker analysis.
    Vaccine. 2026;80:128535.
    >> Share

  37. YITBAREK K, Sheel M, Woldie M, Mahimbo A, et al
    Spatial and temporal trends of measles and measles vaccination status in Ethiopia, 2015-2024.
    Vaccine. 2026;80:128524.
    >> Share

  38. HOOPER ME, Jojo N, Davis D, Blackburn J, et al
    Factors influencing vaccine uptake in people from culturally and linguistically diverse communities in Australia: An integrative review.
    Vaccine. 2026;80:128528.
    >> Share


    Virology

  39. LIU R, Patterson L, Yeasmin M, Kim KH, et al
    Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
    Virology. 2026;619:110884.
    >> Share

  40. CHUNG YJ, Oh HS, Kim SO, Hong SP, et al
    Protective efficacy of GMAI-02, a cDNA-derived inactivated hepatitis A vaccine, against HM175/mp7 challenge in interferon-receptor-deficient mice.
    Virology. 2026;619:110883.
    >> Share


    Virus Res

  41. SITHOLE MN, Khan MR, Mohammed HA, Khan RA, et al
    A Systematic Review on Vaccine Developmental Approaches: Evaluating Efficacy, and Addressing Challenges of Infectious Diseases in the Post-COVID-19 Era.
    Virus Res. 2026 Apr 1:199720. doi: 10.1016/j.virusres.2026.199720.
    >> Share

  42. YUNUS AO, Olanrewaju OA
    Fractional-order Modeling of Vaccination Strategies for Measles Transmission Incorporating Immune Memory.
    Virus Res. 2026 Mar 28:199718. doi: 10.1016/j.virusres.2026.199718.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016